Our business page hero

What We Do

Creating a healthier world through affordable biologics

What We Do

We develop and manufacture biologic medicines across multiple therapeutic areas, including autoimmune diseases, oncology, metabolic disorders, infertility, and infectious disease.

Our portfolio includes recombinant proteins, monoclonal antibodies, and biosimilars, each requiring rigorous characterization, tightly controlled production systems, and consistent clinical performance.

We don't see biologics as "products." We see them as living science, and we treat them with the precision and respect that living science demands.

Core Strategic Pillars

Industrial Maturity

Industrial Maturity

CinnaGen has spent over 30 years refining its scientific and industrial capabilities. What began as a focused research initiative has matured into the region's most sophisticated infrastructure for biosimilar manufacturing, bridging the gap between academic discovery and large-scale pharmaceutical production.
A Catalyst for Innovation

A Catalyst for Innovation

By spearheading the transition to industrial-scale biotechnology, CinnaGen effectively redefined the national pharmaceutical landscape. This leadership is sustained by a high-caliber talent pool and a persistent investment in R&D, turning complex scientific challenges into viable therapeutic solutions.
Uncompromising Quality

Uncompromising Quality

Operational excellence is anchored in strict EU-GMP compliance. By integrating these international benchmarks into every phase of the lifecycle, from molecular formulation to final packaging, the company ensures that safety, purity, and clinical potency are inherent properties of every product.
Global Integration

Global Integration

CinnaGen operates at the intersection of international trade and advanced science, maintaining a competitive presence alongside global biotech leaders. With a distribution network encompassing more than 70 countries across Eurasia, the Middle East, Latin America, and Africa, the organization serves as a critical link in the global healthcare supply chain.

Our Business

Discover what makes CinnaGen a leader in the biopharmaceutical industry